[A contribution to the cytostatic long-term chemotherapy of polycythemia vera (author's transl)]. 1979

W Fereberger, and F P Robier, and S Sailer

From 1967 to 1978 38 patients with polycythemia vera received a long term cytostatic chemotherapy. The results of 14 patients who were given Procarbacin (Natulan) during a mean treatment time of 9 1/2 years are communicated. Two patients showed secondary tumors after 9 or 11 years respectively. The advantages and disadvantages of the various therapeutic approaches in the management of polycythemia in the literature are discussed together with our own experiences.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

W Fereberger, and F P Robier, and S Sailer
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
W Fereberger, and F P Robier, and S Sailer
April 1980, Rinsho shinkeigaku = Clinical neurology,
W Fereberger, and F P Robier, and S Sailer
January 1979, Zhonghua fang she xue za zhi Chinese journal of radiology,
W Fereberger, and F P Robier, and S Sailer
May 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
W Fereberger, and F P Robier, and S Sailer
January 1949, Zeitschrift fur Kinderheilkunde,
W Fereberger, and F P Robier, and S Sailer
July 1976, Vnitrni lekarstvi,
W Fereberger, and F P Robier, and S Sailer
January 1974, Nouvelle revue francaise d'hematologie,
W Fereberger, and F P Robier, and S Sailer
July 1986, Gematologiia i transfuziologiia,
W Fereberger, and F P Robier, and S Sailer
December 1974, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
W Fereberger, and F P Robier, and S Sailer
November 1953, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!